Literature DB >> 17653578

Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.

Sharon Kemp1, Nial J Wheate, Shaoyu Wang, J Grant Collins, Stephen F Ralph, Anthony I Day, Vincent J Higgins, Janice R Aldrich-Wright.   

Abstract

The partial encapsulation of platinum(II)-based DNA intercalators of the type [Pt(5-Cl-phen)(ancillary ligand)](2+), where 5-Cl-phen is 5-chloro-1,10-phenanthroline and the ancillary ligand is ethylenediamine, (1S,2S)-diaminocyclohexane (S,S-dach) or (1R,2R)-diaminocyclohexane, within cucurbit[n]uril (CB[n], where n is 6, 7 or 8) has been examined by (1)H and (195)Pt NMR and mass spectrometry. For CB[7], the molecule encapsulates over the ancillary ligand of all metal complexes, whether this is ethylenediamine or diaminocyclohexane. For CB[8], encapsulation occurs over the sides of the 5-Cl-phen ligand at low [Pt(5-Cl-phen)(S,S-dach)](2+) (5CLSS) to CB[8] ratios (i.e. 0.25:1) but over the ancillary ligand at higher ratios (i.e. 2:1). For CB[6] binding, 5CLSS exhibits both portal and cavity binding, with the ancillary ligand displaying chemical shifts consistent with fast exchange kinetics on the NMR timescale for portal binding and slow exchange kinetics for cavity binding. Binding constants could not be determined using UV-vis, circular dichroism or fluorescence spectrophotometry, but a binding constant for binding of 5CLSS to CB[6] of approximately 10(5) M(-1) was determined using (1)H NMR. Finally, the effect of CB[n] encapsulation on the cytotoxicity of the metal complexes was examined using L1210 murine leukaemia cells in vitro growth inhibition assays. The cytotoxicity is highly dependent on both the metal complex and the CB[n] size, and whilst CB[7] and CB[8] generally decreased cytotoxicity, it was found that CB[6] increased the cyotoxicity of 5CLSS up to 2.5-fold.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653578     DOI: 10.1007/s00775-007-0269-z

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  27 in total

1.  Controlling factors in the synthesis of cucurbituril and its homologues.

Authors:  A Day; A P Arnold; R J Blanch; B Snushall
Journal:  J Org Chem       Date:  2001-11-30       Impact factor: 4.354

2.  Selective Inclusion of a Hetero-Guest Pair in a Molecular Host: Formation of Stable Charge-Transfer Complexes in Cucurbit

Authors:  Hee-Joon Kim; Jungseok Heo; Woo Sung Jeon; Eunsung Lee; Jaheon Kim; Shigeru Sakamoto; Kentaro Yamaguchi; Kimoon Kim
Journal:  Angew Chem Int Ed Engl       Date:  2001-04-17       Impact factor: 15.336

3.  Cucurbit[n]uril binding of platinum anticancer complexes.

Authors:  Nial J Wheate; Damian P Buck; Anthony I Day; J Grant Collins
Journal:  Dalton Trans       Date:  2005-11-28       Impact factor: 4.390

4.  Binding interactions between the host cucurbit[7]uril and dendrimer guests containing a single ferrocenyl residue.

Authors:  David Sobransingh; Angel E Kaifer
Journal:  Chem Commun (Camb)       Date:  2005-09-13       Impact factor: 6.222

Review 5.  DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis.

Authors:  Nial J Wheate; Craig R Brodie; J Grant Collins; Sharon Kemp; Janice R Aldrich-Wright
Journal:  Mini Rev Med Chem       Date:  2007-06       Impact factor: 3.862

6.  A 1H NMR study of the oligonucleotide binding of [(en)Pt(mu-dpzm)2Pt(en)]Cl4.

Authors:  N J Wheate; J G Collins
Journal:  J Inorg Biochem       Date:  2000-03       Impact factor: 4.155

7.  Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4'-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes.

Authors:  N J Wheate; C Cullinane; L K Webster; J G Collins
Journal:  Anticancer Drug Des       Date:  2001 Apr-Jun

8.  Multi-nuclear platinum complexes encapsulated in cucurbit[n]uril as an approach to reduce toxicity in cancer treatment.

Authors:  Nial J Wheate; Anthony I Day; Rodney J Blanch; Alan P Arnold; Carleen Cullinane; J Grant Collins
Journal:  Chem Commun (Camb)       Date:  2004-05-18       Impact factor: 6.222

9.  The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.

Authors:  Sharon Kemp; Nial J Wheate; Damian P Buck; Marica Nikac; J Grant Collins; Janice R Aldrich-Wright
Journal:  J Inorg Biochem       Date:  2007-05-04       Impact factor: 4.155

10.  Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity.

Authors:  Dianne M Fisher; Patrick J Bednarski; Renate Grünert; Peter Turner; Ronald R Fenton; Janice R Aldrich-Wright
Journal:  ChemMedChem       Date:  2007-04       Impact factor: 3.466

View more
  2 in total

1.  Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.

Authors:  Johnny Moretto; Bruno Chauffert; François Ghiringhelli; Janice R Aldrich-Wright; Florence Bouyer
Journal:  Invest New Drugs       Date:  2010-06-10       Impact factor: 3.850

2.  Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator.

Authors:  Shaoyu Wang; Vincent J Higgins; Janice R Aldrich-Wright; Ming J Wu
Journal:  J Chem Biol       Date:  2011-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.